Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression (Q30501271)

13 October 2017

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression (English)

1 reference

13 October 2017

1 reference

0 references

0 references

5

1 reference

13 October 2017

8

Joseph Jankovic

1 reference

13 October 2017

19

Jing Zhang

1 reference

13 October 2017

12

Thomas J Montine

1 reference

13 October 2017

7

Douglas Galasko

1 reference

13 October 2017

6

Elaine R Peskind

1 reference

13 October 2017

Min Shi

1

1 reference

13 October 2017

Joshua Bradner

2

1 reference

13 October 2017

Aneeka M Hancock

3

1 reference

13 October 2017

Kathryn A Chung

4

1 reference

13 October 2017

Hojoong M Kim

10

1 reference

13 October 2017

James B Leverenz

11

1 reference

13 October 2017

Carmen Ginghina

13

1 reference

13 October 2017

Un Jung Kang

14

1 reference

13 October 2017

Kevin C Cain

15

1 reference

13 October 2017

Yu Wang

16

1 reference

13 October 2017

Jan Aasly

17

1 reference

13 October 2017

David Goldstein

18

1 reference

13 October 2017

11 March 2011

1 reference

13 October 2017

1 reference

13 October 2017

69

1 reference

13 October 2017

3

1 reference

13 October 2017

570-580

1 reference

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Microglial activation in Alzheimer's disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Biological fluid biomarkers in neurodegenerative parkinsonism

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Fractalkine and TGF-beta1 levels reflect the severity of chronic pancreatitis in humans

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Sniffing out Parkinson disease: can olfactory testing differentiate parkinsonian disorders?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Association of olfactory dysfunction with risk for future Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Neuronal 'On' and 'Off' signals control microglia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

The etiopathogenesis of Parkinson disease and suggestions for future research. Part I.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Control of microglial neurotoxicity by the fractalkine receptor

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

FLT3: receptor and ligand

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Neuropathological spectrum of synucleinopathies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Both total and phosphorylated tau are increased in Alzheimer's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Cerebrospinal-fluid tau protein and aspartate aminotransferase in Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Biomarkers in Huntington's and Parkinson's Disease

20 June 2018

1 reference

Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease

21 January 2018

1 reference

Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?

21 January 2018

1 reference

21 January 2018

1 reference

Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease.

21 January 2018

1 reference

Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.

21 January 2018

1 reference

Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease

21 January 2018

1 reference

Blood-based neurochemical diagnosis of vascular dementia: a pilot study.

21 January 2018

1 reference

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

21 January 2018

1 reference

Cerebrospinal fluid Abeta42 levels in multiple system atrophy.

21 January 2018

1 reference

CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease

21 January 2018

1 reference

Tau protein concentrations in cerebrospinal fluid of non-demented Parkinson's disease patients.

21 January 2018

1 reference

Mini ReviewFLT3: Receptor and Ligand

21 January 2018

1 reference

The FLT3 tyrosine kinase receptor inhibits neural stem/progenitor cell proliferation and collaborates with NGF to promote neuronal survival.

21 January 2018

1 reference

Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse

21 January 2018

1 reference

Tauopathies and synucleinopathies: Do cerebrospinal fluid β-amyloid peptides reflect disease-specific pathogenesis?

21 January 2018

1 reference

Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia

21 January 2018

1 reference

Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117674

Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies

26 November 2018

1 reference

12 December 2020

Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy

1 reference

12 December 2020

DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Parkinson Study Group

1 reference

12 December 2020

Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation

1 reference

12 December 2020

Neural progenitors, neurons and oligodendrocytes from human umbilical cord blood cells in a serum-free, feeder-free cell culture

1 reference

12 December 2020

Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF

1 reference

12 December 2020

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

1 reference

12 December 2020

Identifiers

DOI

10.1002/ANA.22311

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

21400565

1 reference